Fauci has now come out saying "If a study that's a good study comes out and shows efficacy and safety for hydroxychloroquine or any other drug that we do, if you do it in the right way, you accept that scientific data, but right now today, the cumulative scientific data that has been put together, and done over a number of different studies, has shown no efficacy."
https://www.axios.com/fauci-trump-hydrox...ntent=1100
The irony is that there is already a cheap, readily available drug that cuts the proportion of hospitalized COVID-19 patients who die by about 1/5 (the effect is larger [~40%] in sicker patients). It's called dexamethasone, it is available for pennies, and it has been proven effective in a large (1110 patient) randomized, placebo controlled study that's been published in a major medical journal.
https://www.nejm.org/doi/full/10.1056/NE...6?query=RP
Like Lex, I hope for positive developments that help us cut the death rate and improve the recovery time of patients with COVID-19. So far, dexamethasone and remdisivir have proven at least somewhat effective. I suspect that as more and more results come in, we'll see more successes, but a lot of failures as well. That is the nature of drug development. I never understood why anyone would hitch their wagon rhetorically to a particular drug, but here we are. The world is littered with drugs that seemed to work in small observational studies that later failed. And were it not for the president's pronouncements, I suspect antimalarials would be in the dustbin along with other failed drugs tried for COVID-19. Like, does anyone talk about antiretrovirals anymore? At one point they too were being looked at to repurpose for COVID-19, but when those trials failed, physicians just stopped using them and moved on. This is why I believe the President's actions have been counterproductive, as I suspect resources are continuing to be wasted chasing the antimalarials (not saying anything is deliberate, but doctors are human too and I wonder if the initial results might have remained obscure had they not been amplified, and HCQ suffered the same fate as lopinavir/ritonavir when studies were negative).
BC